Kalehua Capital Management’s Milestone Pharmaceuticals MIST Stock Holding History

Kalehua Capital Management’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.7M	Buy	+1,269,237	New	+$2.03M	1.22%	20

Other funds holding MIST

PCM

Pavaki Capital Management Pueblo, Colorado $287M AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

LPC

Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Kalehua Capital Management's MIST Position: Q2 2026 in Review

Kalehua Capital Management opened a new position in Milestone Pharmaceuticals (MIST) in Q2 2026: 1,269,237 shares worth $1.7M. The stake represents 1.22% of the portfolio and ranks #20 among its holdings.

76 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

Kalehua Capital Management held 1,269,237 shares of Milestone Pharmaceuticals worth $1.7M as of Q2 2026.
Milestone Pharmaceuticals was a new Kalehua Capital Management position in Q2 2026.
Milestone Pharmaceuticals made up 1.22% of Kalehua Capital Management's portfolio in Q2 2026, its #20 holding.
76 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Kalehua Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.